SCHEMBL30927052

SCHEMBL30927052

CN(c1ccccc1)S(=O)(=O)c1cccc(NC(=O)c2cccs2)c1

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.77
▸ KMT2A Q03164 3/20 0.77
▸ MEN1 O00255 2/20 0.77
▸ MAPK1 P28482 5/20 0.60
▸ ALDH1A1 P00352 3/20 0.60
▸ HTT P42858 4/20 0.59
▸ SMN1; SMN2 Q16637 4/20 0.59
▸ LMNA P02545 2/20 0.59
▸ L3MBTL1 Q9Y468 2/20 0.59
▸ KCNK3 O14649 1/20 0.57
▸ KCNK9 Q9NPC2 1/20 0.57
▸ GAA P10253 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ POLB P06746 1/20 0.57
▸ PKM P14618 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ ADRB2 P07550 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179645 1.00 MAPT (0.77) MAPTKMT2AMEN1MAPK1ALDH1A1
SCHEMBL27180778 0.84 MAPK1 (0.62) MAPTKMT2AMEN1MAPK1ALDH1A1
SCHEMBL27181372 0.82 L3MBTL1 (0.59) MAPTKMT2AMEN1MAPK1ALDH1A1
SCHEMBL27181168 0.82 MAPK1 (0.58) MAPTKMT2AMEN1MAPK1ALDH1A1
SCHEMBL30926486 0.81 MAPK1 (0.63) MAPTKMT2AMEN1MAPK1ALDH1A1
SCHEMBL27179761 0.81 MAPK1 (0.63) MAPTKMT2AMEN1MAPK1ALDH1A1
SCHEMBL30926929 0.81 LMNA (0.76) MAPTKMT2AMEN1MAPK1ALDH1A1
SCHEMBL27180161 0.81 LMNA (0.76) MAPTKMT2AMEN1MAPK1ALDH1A1
SCHEMBL833815 0.80 SMN1; SMN2 (0.65) MAPTKMT2AMEN1MAPK1HTT
SCHEMBL30926499 0.78 LMNA (0.76) MAPTKMT2AMEN1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MAPT 4236/4885KMT2A 2544/4885MEN1 4795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback